Claude Lemarié
About
Claude Lemarié is a scholar working on Hematology, Oncology and Immunology.
According to data from OpenAlex, Claude Lemarié has authored 62 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Hematology, 17 papers in Oncology and 17 papers in Immunology. Recurrent topics in Claude Lemarié's work include Hematopoietic Stem Cell Transplantation (49 papers), Acute Myeloid Leukemia Research (13 papers) and Acute Lymphoblastic Leukemia research (10 papers). Claude Lemarié is often cited by papers focused on Hematopoietic Stem Cell Transplantation (49 papers), Acute Myeloid Leukemia Research (13 papers) and Acute Lymphoblastic Leukemia research (10 papers). Claude Lemarié collaborates with scholars based in France, Italy and United States. Claude Lemarié's co-authors include Christian Chabannon, Boris Calmels, Didier Blaise, Catherine Faucher, Sabine Fürst, Angéla Granata, Luca Castagna, Jean El Cheikh, Roberto Crocchiolo and Patrick Ladaique and has published in prestigious journals such as Circulation, Blood and PLoS ONE.
In The Last Decade
Claude Lemarié
60 papers receiving 882 citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Claude Lemarié France | 18 | 630 | 245 | 232 | 149 | 121 | 62 | 904 | ||
| Alan Le Canada | 10 | 341 0.5× | 284 1.2× | 347 1.5× | 66 0.4× | 90 0.7× | 13 | 939 | ||
| A N Békássy Sweden | 17 | 958 1.5× | 134 0.5× | 305 1.3× | 309 2.1× | 147 1.2× | 31 | 1.4k | ||
| G. Ehninger Germany | 15 | 463 0.7× | 96 0.4× | 170 0.7× | 110 0.7× | 144 1.2× | 56 | 859 | ||
| EC Guinan United States | 9 | 365 0.6× | 175 0.7× | 200 0.9× | 97 0.7× | 63 0.5× | 14 | 734 | ||
| GP Herzig United States | 12 | 564 0.9× | 109 0.4× | 175 0.8× | 173 1.2× | 122 1.0× | 14 | 870 | ||
| W.Y. Au China | 14 | 297 0.5× | 110 0.4× | 134 0.6× | 68 0.5× | 164 1.4× | 37 | 713 | ||
| NKC Ramsay United States | 11 | 239 0.4× | 45 0.2× | 247 1.1× | 98 0.7× | 45 0.4× | 11 | 630 | ||
| Serdar Şıvgın Türkiye | 15 | 370 0.6× | 89 0.4× | 119 0.5× | 45 0.3× | 331 2.7× | 53 | 713 | ||
| Junji Tomiyama Japan | 13 | 235 0.4× | 153 0.6× | 90 0.4× | 50 0.3× | 100 0.8× | 47 | 565 | ||
| Photis Beris Switzerland | 16 | 466 0.7× | 92 0.4× | 48 0.2× | 23 0.2× | 308 2.5× | 44 | 796 |
Countries citing papers authored by Claude Lemarié
Since
Specialization
Citations
This map shows the geographic impact of Claude Lemarié's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude Lemarié with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude Lemarié more than expected).
Fields of papers citing papers by Claude Lemarié
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Claude Lemarié. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude Lemarié. The network helps show where Claude Lemarié may publish in the future.
Co-authorship network of co-authors of Claude Lemarié
This figure shows the co-authorship network connecting the top 25 collaborators of Claude Lemarié. A scholar is included among the top collaborators of Claude Lemarié based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claude Lemarié. Claude Lemarié is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Fürst, Sabine, Boris Calmels, Thomas Pagliardini, et al.. (2023). GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 58(11). 1179–1181.
2.
Mfarrej, Bechara, et al.. (2022). Sepax-2 cell processing device: a study assessing reproducibility of concentrating thawed hematopoietic progenitor cells. Journal of Translational Medicine. 20(1). 503–503.
3.
Martin, E., Claude Lemarié, Pascal Jézéquel, et al.. (2021). 156P Impact of HER2 status (HER2-low versus HER2-0) on complete histologic response after neoadjuvant chemotherapy in early triple-negative breast cancer (TNBC). Annals of Oncology. 32. S428–S429.
4.
Couturaud, Françis, et al.. (2021). TLR3 promotes venous thrombosis through neutrophil recruitment. Archives of Cardiovascular Diseases Supplements. 13(2). 183–183.
5.
Garciaz, Sylvain, Angéla Granata, Boris Calmels, et al.. (2020). Analysis of a large single institution cohort of related donors fails to detect a relation between SDF1/CXCR4 or VCAM/VLA4 genetic polymorphisms and the level of hematopoietic progenitor cell mobilization in response to G-CSF. PLoS ONE. 15(3). e0228878–e0228878.
6.
Fürst, Sabine, Valério Maisano, Agnès Basire, et al.. (2020). Successful Clearance of Donor Specific Anti-HLA Antibodies after Desensitization with Rituximab, Velcade and Plasma-Exchange Followed By a Haploidentical Stem Cell Transplantion with Post-Transplantation Cyclophosphamide. Blood. 136(Supplement 1). 12–12.
7.
Chabannon, Christian, Réda Bouabdallah, S. Fürst, et al.. (2019). CAR-T cells : lymphocytes exprimant un récepteur chimérique à l’antigène. La Revue de Médecine Interne. 40(8). 545–552.
8.
Devillier, Raynier, Faézeh Legrand, Jérôme Rey, et al.. (2018). HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison. Biology of Blood and Marrow Transplantation. 24(7). 1449–1454.
9.
Boudin, Laurys, Christian Chabannon, Renaud Sabatier, et al.. (2016). Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation. European Journal of Cancer. 57. 118–126.
10.
Granata, Angéla, et al.. (2016). An intra-patient comparison of blood cell separators Spectra and Optia in patients and donors undergoing blood mononuclear cell collections at a single institution for subsequent autologous or allogeneic hematopoietic cell transplantation reveals comparable collection efficiencies. Bone Marrow Transplantation. 51(7). 1007–1009.
11.
Crocchiolo, Roberto, Sabine Fürst, Angéla Granata, et al.. (2016). The efficacy and safety of a new reduced-toxicity conditioning with 4 days of once-daily 100 mg/m2intravenous busulfan associated with fludarabine and antithymocyte globulins prior to allogeneic stem cell transplantation in patients with high-risk myelodysplastic syndrome or acute leukemia. Leukemia & lymphoma. 57(10). 2315–2320.
12.
Devillier, Raynier, Sabine Fürst, Roberto Crocchiolo, et al.. (2014). Poor Outcome with Nonmyeloablative Conditioning Regimen before Cord Blood Transplantation for Patients with High-Risk Acute Myeloid Leukemia Compared with Matched Related or Unrelated Donor Transplantation. Biology of Blood and Marrow Transplantation. 20(10). 1560–1565.
13.
Fürst, Sabine, E. Bernit, Jean El Cheikh, et al.. (2014). Successfull Engraftment and Clearance of Donor Specific Antibodies after Haploidentical Related Stem Cell Transplantation for an Adult Patient with Sickle Cell Disease. Blood. 124(21). 5792–5792.
14.
Klyuchnikov, Evgeny, Jean El Cheikh, Andreas Sputtek, et al.. (2013). CD34+-Selected Stem Cell Boost without Further Conditioning for Poor Graft Function after Allogeneic Stem Cell Transplantation in Patients with Hematological Malignancies. Biology of Blood and Marrow Transplantation. 20(3). 382–386.
15.
Devillier, Raynier, Sabine Fürst, Jean El Cheikh, et al.. (2013). Antithymocyte Globulin in Reduced-Intensity Conditioning Regimen Allows a High Disease-Free Survival Exempt of Long-Term Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 20(3). 370–374.
16.
Cheikh, Jean El, Boris Calmels, Claude Lemarié, et al.. (2011). Age at transplantation and outcome after autologous stem cell transplantation in elderly patients with multiple myeloma. Hematology/Oncology and Stem Cell Therapy. 4(1). 30–36.
17.
Cheikh, Jean El, Sabine Fürst, Anne Marie Stoppa, et al.. (2011). Allogeneic Hematopoietic Stem-Cell Transplantation with Reduced-Intensity Conditioning in Patients with High Risk Multiple Myeloma: Comparative Analysis of Outcomes Between Unrelated and Related Donor. Blood. 118(21). 4513–4513.
18.
Panterne, Béatrice, Fabienne Pouthier, Véronique Decot, et al.. (2010). Contrôle de qualité des greffons de sang placentaire décongelés : résultats d’une étude multicentrique. Transfusion Clinique et Biologique. 17(2). 41–46.
19.
Blaise, Didier, Catherine Faucher, Sabine Fürst, et al.. (2007). The Dose of CD34+ Cells Negatively Impacts the Outcome of Patients Treated with Genoidentical Allo SCT Prepared with a Reduced Intensity Conditioning (RIC).. Blood. 110(11). 1086–1086.
20.
Lemarié, Claude, Benjamin Esterni, Boris Calmels, et al.. (2007). CD34+ progenitors are reproducibly recovered in thawed umbilical grafts, and positively influence haematopoietic reconstitution after transplantation. Bone Marrow Transplantation. 39(8). 453–460.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Alan Le Breakdown of academic impact, for papers by A N Békássy Breakdown of academic impact, for papers by G. Ehninger Breakdown of academic impact, for papers by EC Guinan Breakdown of academic impact, for papers by GP Herzig Breakdown of academic impact, for papers by W.Y. Au Breakdown of academic impact, for papers by NKC Ramsay Breakdown of academic impact, for papers by Serdar Şıvgın Breakdown of academic impact, for papers by Junji Tomiyama Breakdown of academic impact, for papers by Photis Beris